Thyroid eye disease (TED), also called Graves’ ophthalmopathy or Graves’ orbitopathy, is an autoimmune disease of the tissues around the eyes. It can cause dryness, pain, puffy lids, eyelid retraction, bulging eyes and double vision. Most cases are mild, but severe corneal exposure or optic-nerve compression can threaten sight.
Book Initial TED Eye AssessmentNew vision loss, reduced color vision, missing areas of visual field, severe corneal exposure or inability to close the eyelids needs urgent ophthalmic assessment.
The U.S. FDA approved LUMVOA (veligrotug-vvze) on 26 June 2026 for TED regardless of disease activity or duration. It joins TEPEZZA (teprotumumab) as an FDA-approved IGF-1 receptor inhibitor. This guide does not assume either drug is currently available in Nepal.
| Topic | Professional Guidance |
|---|---|
| TED | Autoimmune orbital disease |
| Other names | Graves ophthalmopathy / orbitopathy |
| Common setting | Graves hyperthyroidism |
| Can occur with normal/low thyroid? | Rarely yes |
| Main symptoms | Dryness, swelling, pain, proptosis, double vision |
| Topic | Professional Guidance |
|---|---|
| Mechanism | Autoimmune inflammation and orbital tissue remodelling |
| Hyperthyroid | Common |
| Euthyroid | Possible |
| Hypothyroid | Possible but uncommon |
| Lesson | Normal thyroid tests do not fully exclude TED |
| Topic | Professional Guidance |
|---|---|
| Surface | Gritty, dry or watery eyes |
| Lids | Puffy or retracted |
| Orbit | Pressure or pain |
| Globe | Proptosis |
| Alignment | Double vision |
| Topic | Professional Guidance |
|---|---|
| Cause | Expanded orbital fat and extraocular muscles |
| Asymmetry | Common |
| Measurement | Exophthalmometry |
| Unilateral rapid change | Needs broader orbital differential |
| Treatment | Activity/severity dependent |
| Topic | Professional Guidance |
|---|---|
| Cause | Restrictive muscle disease |
| Pattern | Gaze-dependent or constant |
| Prism | May help selected patients |
| Surgery | Usually after stability |
| Sudden diplopia | Needs assessment |
| Topic | Professional Guidance |
|---|---|
| Feature | Upper lid sits high |
| Effect | Exposure and staring appearance |
| Active disease | May change |
| Inactive disease | May persist |
| Surgery | Usually rehabilitative after stability |
| Topic | Professional Guidance |
|---|---|
| Meaning | Incomplete eyelid closure |
| Risk | Corneal exposure |
| Symptoms | Burning, morning irritation |
| Severe | Epithelial breakdown possible |
| Action | Prompt ophthalmology if pain/redness/vision loss |
| Topic | Professional Guidance |
|---|---|
| Cause | Proptosis + lid retraction |
| Early | Dryness and epithelial staining |
| Advanced | Persistent defect or ulceration |
| Support | Lubrication / nighttime protection as advised |
| Severe | Sight-threatening |
| Topic | Professional Guidance |
|---|---|
| Meaning | Optic-nerve compromise from TED |
| Clues | Reduced acuity, color desaturation, field loss |
| Imaging | CT/MRI may help |
| Urgency | Sight-threatening |
| Action | Urgent specialist care |
| Topic | Professional Guidance |
|---|---|
| Color | New desaturation is concerning |
| Field | Missing/dim areas are concerning |
| Cause | Possible optic-nerve compression |
| Testing | Color, pupils, fields, imaging |
| Urgency | Prompt/urgent |
| Topic | Professional Guidance |
|---|---|
| Smoking | Major modifiable risk factor |
| Secondhand smoke | Avoid |
| Disease course | Can be worse |
| Treatment response | May be poorer |
| Action | Smoking cessation support |
| Topic | Professional Guidance |
|---|---|
| Hyperthyroidism | Can worsen TED |
| Hypothyroidism | Can worsen TED |
| Goal | Euthyroidism |
| Medication | Do not self-adjust |
| Team | Endocrinology + ophthalmology |
| Topic | Professional Guidance |
|---|---|
| Risk | May worsen TED in susceptible patients |
| Higher risk | Smoking / pre-existing TED |
| Not universally banned | Individual decision |
| Prophylaxis | May be considered by specialist |
| Decision | Endocrinologist-led |
| Topic | Professional Guidance |
|---|---|
| Active | Inflammation/change |
| Inactive | Residual structural changes |
| Why important | Treatment differs |
| Duration | Variable |
| Biologic labels | Current U.S. IGF-1R labels are regardless of activity/duration |
| Topic | Professional Guidance |
|---|---|
| Purpose | Inflammatory activity |
| Includes | Pain, redness, swelling |
| Does not fully represent | Proptosis, diplopia, DON, QoL |
| Use | Combine with severity |
| Caution | Do not treat by CAS alone |
| Topic | Professional Guidance |
|---|---|
| Lubrication | Surface relief |
| Night protection | If incomplete closure |
| Sunglasses | Light/wind comfort |
| Smoking | Stop/avoid |
| Thyroid status | Keep controlled |
| Topic | Professional Guidance |
|---|---|
| Evidence | Selected mild active disease in guideline context |
| Nutrition | Baseline status matters |
| Nepal | No universal recommendation |
| Risk | Excess can be toxic |
| Action | Clinician advice |
| Topic | Professional Guidance |
|---|---|
| Features | Meaningful proptosis/diplopia/inflammation/QoL impact |
| EUGOGO | IV glucocorticoid-based therapy often with mycophenolate |
| ATA/ETA | Individualized phenotype-based treatment |
| Biologics | May be considered where available |
| Setting | Specialist centre |
| Topic | Professional Guidance |
|---|---|
| Role | Guideline-supported in active moderate-severe disease |
| Risks | Liver, cardiovascular, metabolic, psychiatric, infection |
| Monitoring | Required |
| Self-use | Never |
| Vision Concern | Not claimed on-site |
| Topic | Professional Guidance |
|---|---|
| Role | Used in EUGOGO first-line framework with IV steroids |
| Type | Systemic immunosuppressant |
| Risks | Infection, blood/liver, pregnancy |
| Monitoring | Required |
| Vision Concern | Not claimed on-site |
| Topic | Professional Guidance |
|---|---|
| Generic | Teprotumumab |
| Class | IGF-1R inhibitor |
| FDA indication | TED regardless of activity/duration |
| Course | 8 IV infusions every 3 weeks |
| Warnings | Infusion reactions, IBD, hyperglycemia, hearing impairment |
| Topic | Professional Guidance |
|---|---|
| Generic | Veligrotug-vvze |
| FDA approval | June 26, 2026 |
| Indication | TED regardless of activity/duration |
| Course | 10 mg/kg IV every 3 weeks for 5 infusions |
| Nepal | Availability not assumed |
| Topic | Professional Guidance |
|---|---|
| Infusion reactions | FDA warning |
| IBD | Warning |
| Hyperglycemia | Warning / monitor glucose |
| Hearing impairment | Warning |
| Pregnancy | Reproductive precautions apply |
| Topic | Professional Guidance |
|---|---|
| Both | U.S.-approved IGF-1R inhibitors |
| TEPEZZA | 8-infusion labeled course |
| LUMVOA | 5-infusion labeled course |
| Safety | Important systemic warnings |
| Choice | Specialist decision |
| Topic | Professional Guidance |
|---|---|
| Issue | Biologic labels warn about hyperglycemia |
| Before | Assess glucose |
| During | Monitor |
| Control | Optimize diabetes |
| Vision Concern | No biologic infusion claim |
| Topic | Professional Guidance |
|---|---|
| Drugs | TEPEZZA and LUMVOA carry hearing warnings |
| History | Disclose baseline problems |
| Symptoms | Report hearing change / tinnitus |
| Monitoring | Specialist-directed |
| Decision | Individual risk-benefit |
| Topic | Professional Guidance |
|---|---|
| Issue | IGF-1R inhibitor labels include IBD warnings |
| History | Disclose Crohn/ulcerative colitis |
| Symptoms | Report new GI symptoms |
| Decision | Specialist risk-benefit |
| Label | Use current prescribing info |
| Topic | Professional Guidance |
|---|---|
| Role | Selected active TED in some frameworks |
| Not universal | Practice differs |
| Planning | Radiation + ophthalmic specialist |
| Retinal disease | May affect suitability |
| Vision Concern | Not claimed |
| Topic | Professional Guidance |
|---|---|
| Purpose | Create orbital space |
| Emergency role | DON / severe compression |
| Inactive role | Residual proptosis |
| Risks | Diplopia, sinus/bleeding etc. |
| Specialist | Orbital/oculoplastic surgeon |
| Topic | Professional Guidance |
|---|---|
| Purpose | Stable restrictive diplopia |
| Timing | Usually after inactivity/stability |
| Sequence | After decompression if needed |
| Goal | Improve alignment |
| Repeat surgery | Sometimes required |
| Topic | Professional Guidance |
|---|---|
| Targets | Retraction/asymmetry/exposure |
| Timing | Usually after stable TED |
| Sequence | After decompression/strabismus if required |
| Exception | Urgent corneal protection |
| Specialist | Oculoplastic |
| Topic | Professional Guidance |
|---|---|
| Use | Reduce diplopia |
| Fresnel | Useful while alignment changes |
| Ground-in | Stable deviations |
| Limit | Large/incomitant deviations |
| Effect | Treats symptom, not TED |
| Topic | Professional Guidance |
|---|---|
| Artificial tears | Surface relief |
| Gel/ointment | Exposure support |
| Night protection | May help |
| Severe exposure | Needs ophthalmology |
| Steroids | Do not self-start |
| Topic | Professional Guidance |
|---|---|
| Photophobia | Comfort |
| Wind | Wrap style may help |
| UV | General protection |
| Appearance | May improve confidence |
| TED | Does not treat autoimmune disease |
| Topic | Professional Guidance |
|---|---|
| Shows | Muscles, fat, apical crowding |
| DON | Helpful for apex |
| Surgery | Planning |
| Radiation | Uses ionizing radiation |
| Use | Not every mild case |
| Topic | Professional Guidance |
|---|---|
| Strength | Soft-tissue detail |
| Radiation | None |
| Use | Atypical / differential / activity |
| Limits | Time, cost, implants |
| Order | Specialist-directed |
| Topic | Professional Guidance |
|---|---|
| Measures | Globe protrusion |
| Use | Baseline/serial tracking |
| Normal | Varies by anatomy/population |
| Trend | Often more useful than one number |
| Availability | Confirm locally |
| Topic | Professional Guidance |
|---|---|
| Team | Obstetric + endocrine + ophthalmic |
| RAI | Not used in pregnancy |
| Biologics | Pregnancy warnings matter |
| Thyroid treatment | Pregnancy-specific |
| Vision loss | Urgent |
| Topic | Professional Guidance |
|---|---|
| Appearance | Proptosis/lid retraction |
| Function | Diplopia affects work/driving |
| Sleep | Exposure symptoms |
| Mental health | Visible disease can be burdensome |
| Assessment | QoL matters |
| Topic | Professional Guidance |
|---|---|
| Usually | Bilateral but asymmetric |
| Unilateral appearance | Possible |
| Very asymmetric | Consider imaging |
| Other causes | Tumor/inflammation etc. |
| Specialist | Orbital assessment |
| Topic | Professional Guidance |
|---|---|
| TED possible? | Rarely yes |
| History | Autoimmune context matters |
| Differential | Other orbital disease |
| Tests | Thyroid antibodies/imaging may be used |
| Diagnosis | Specialist |
| Topic | Professional Guidance |
|---|---|
| Can occur? | Yes |
| RAI | Can increase risk in susceptible people |
| Thyroidectomy | Does not instantly reverse TED |
| Antithyroid meds | Control thyroid, not direct orbital inflammation |
| Monitor | New eye symptoms |
| Topic | Professional Guidance |
|---|---|
| Overlap | Burning, grittiness, tearing |
| TED clues | Proptosis, lid retraction, diplopia |
| Dry eye | Does not cause true proptosis |
| Red flag | Color/field/vision loss |
| Action | Examine persistent symptoms |
| Topic | Professional Guidance |
|---|---|
| Allergy | Itching prominent |
| TED | Pressure, proptosis, diplopia |
| Coexist | Possible |
| Rubbing | Avoid excessive rubbing |
| Orbital signs | Need review |
| Topic | Professional Guidance |
|---|---|
| TED | Often bilateral/asymmetric pattern |
| Tumor | May be unilateral/displacing |
| Rapid change | Needs imaging |
| Thyroid history | Does not exclude other disease |
| Specialist | Oculoplastic/orbital |
| Topic | Professional Guidance |
|---|---|
| Bring | Thyroid labs, meds, imaging, prior treatment |
| Stable mild | Initial eye exam |
| Vision/color change | Urgent ophthalmology |
| Biologic access | Do not assume local availability |
| Thamel | Lazimpat is nearby |
| Topic | Professional Guidance |
|---|---|
| Care | Coordinate endocrinology/ophthalmology |
| Smoking | Avoid |
| Thyroid levels | Keep controlled |
| Insurance | Check specialist/imaging coverage |
| Vision Concern | English-speaking initial assessment |
| Topic | Professional Guidance |
|---|---|
| Branch | No Vision Concern branch in Thamel |
| Nearby | Lazimpat |
| Initial exam | Available |
| Specialist TED management | Referral |
| Emergency | Hospital-level care |
| Topic | Professional Guidance |
|---|---|
| Exam | Comprehensive eye examination |
| Refraction | Available |
| Visible eye-health check | Available |
| Referral | Current page explicitly supports referral |
| Not claimed | TED infusions, IV steroids, radiotherapy or surgery |
| Topic | Professional Guidance |
|---|---|
| Vision | Compare acuity each eye |
| Color | Ask about desaturation |
| Diplopia | Direction/frequency |
| Surface | Exposure/corneal integrity |
| Activity | Pain/redness/swelling |
| Topic | Professional Guidance |
|---|---|
| Endocrinology | Thyroid control |
| Ophthalmology | TED activity/severity |
| Oculoplastics | Orbit/lids |
| Strabismus/orthoptics | Diplopia |
| Primary care | Smoking, diabetes, systemic risk |
| Topic | Professional Guidance |
|---|---|
| Treat thyroid = eyes instantly normal | False |
| Bulging eye always Graves | False |
| All TED needs surgery | False |
| Normal thyroid tests rule it out | False |
| Sunglasses cure TED | False |
| Topic | Professional Guidance |
|---|---|
| Thyroid labs | Recent if available |
| Medicines | Full list |
| Smoking history | Current/former/passive |
| Imaging | CT/MRI |
| Old photos | Document change |
| Topic | Professional Guidance |
|---|---|
| Exam | Current comprehensive service |
| Referral | Medical referral pathway |
| English | Tourist/expat support |
| Branches | Lazimpat, Boudha-Tushal, Makalbari |
| Hours | 08:00 AM–08:30 PM daily incl. public holidays |
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Vision Concern can provide an initial comprehensive eye assessment and referral. Moderate, severe or sight-threatening TED needs specialist ophthalmic/endocrine care.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
TED can cause restrictive double vision. Prism may help selected patients, while surgery is generally planned after alignment stabilizes.
TED can cause restrictive double vision. Prism may help selected patients, while surgery is generally planned after alignment stabilizes.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
New loss of acuity, color vision or visual field can signal sight-threatening TED and needs urgent ophthalmic assessment.
New loss of acuity, color vision or visual field can signal sight-threatening TED and needs urgent ophthalmic assessment.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
New loss of acuity, color vision or visual field can signal sight-threatening TED and needs urgent ophthalmic assessment.
New loss of acuity, color vision or visual field can signal sight-threatening TED and needs urgent ophthalmic assessment.
New loss of acuity, color vision or visual field can signal sight-threatening TED and needs urgent ophthalmic assessment.
Smoking and secondhand smoke exposure are recognized modifiable risk factors for TED development or worsening.
Smoking and secondhand smoke exposure are recognized modifiable risk factors for TED development or worsening.
Smoking and secondhand smoke exposure are recognized modifiable risk factors for TED development or worsening.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Radioactive iodine can worsen TED in susceptible people, particularly smokers or those with existing eye disease; endocrinology should guide treatment choice.
Radioactive iodine can worsen TED in susceptible people, particularly smokers or those with existing eye disease; endocrinology should guide treatment choice.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
New loss of acuity, color vision or visual field can signal sight-threatening TED and needs urgent ophthalmic assessment.
Selenium has evidence in selected mild active Graves orbitopathy, but it should not be universally self-prescribed.
Systemic immunosuppressive treatment requires specialist selection, screening and monitoring; Vision Concern does not claim to provide it on-site.
Systemic immunosuppressive treatment requires specialist selection, screening and monitoring; Vision Concern does not claim to provide it on-site.
Systemic immunosuppressive treatment requires specialist selection, screening and monitoring; Vision Concern does not claim to provide it on-site.
TEPEZZA is a U.S. FDA-approved IGF-1R inhibitor for TED regardless of activity or duration, with important warnings including hyperglycemia, inflammatory bowel disease and hearing impairment.
TEPEZZA is a U.S. FDA-approved IGF-1R inhibitor for TED regardless of activity or duration, with important warnings including hyperglycemia, inflammatory bowel disease and hearing impairment.
TEPEZZA is a U.S. FDA-approved IGF-1R inhibitor for TED regardless of activity or duration, with important warnings including hyperglycemia, inflammatory bowel disease and hearing impairment.
LUMVOA (veligrotug-vvze) received U.S. FDA approval in June 2026 for TED regardless of activity or duration. This guide does not claim current Nepal availability.
LUMVOA (veligrotug-vvze) received U.S. FDA approval in June 2026 for TED regardless of activity or duration. This guide does not claim current Nepal availability.
LUMVOA (veligrotug-vvze) received U.S. FDA approval in June 2026 for TED regardless of activity or duration. This guide does not claim current Nepal availability.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Orbital, strabismus and eyelid surgery are specialist procedures used for specific TED problems, usually after stability except in sight-threatening emergencies.
Orbital, strabismus and eyelid surgery are specialist procedures used for specific TED problems, usually after stability except in sight-threatening emergencies.
Orbital, strabismus and eyelid surgery are specialist procedures used for specific TED problems, usually after stability except in sight-threatening emergencies.
Orbital, strabismus and eyelid surgery are specialist procedures used for specific TED problems, usually after stability except in sight-threatening emergencies.
TED can cause restrictive double vision. Prism may help selected patients, while surgery is generally planned after alignment stabilizes.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Current IGF-1R inhibitor labels warn about hyperglycemia, so glucose assessment and control matter before and during treatment.
Current FDA labels for TEPEZZA and LUMVOA include hearing-impairment warnings.
Current FDA labels for IGF-1R inhibitors include inflammatory-bowel-disease warnings; specialist risk assessment is required.
Current IGF-1R inhibitor labels warn about hyperglycemia, so glucose assessment and control matter before and during treatment.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Vision Concern can provide an initial comprehensive eye assessment and referral. Moderate, severe or sight-threatening TED needs specialist ophthalmic/endocrine care.
Vision Concern can provide an initial comprehensive eye assessment and referral. Moderate, severe or sight-threatening TED needs specialist ophthalmic/endocrine care.
Vision Concern can provide an initial comprehensive eye assessment and referral. Moderate, severe or sight-threatening TED needs specialist ophthalmic/endocrine care.
Ask the relevant provider for today's exact fee. This article does not invent current TED examination, imaging, drug or surgery prices.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Vision Concern can provide an initial comprehensive eye assessment and referral. Moderate, severe or sight-threatening TED needs specialist ophthalmic/endocrine care.
Orbital, strabismus and eyelid surgery are specialist procedures used for specific TED problems, usually after stability except in sight-threatening emergencies.
Vision Concern can provide an initial comprehensive eye assessment and referral. Moderate, severe or sight-threatening TED needs specialist ophthalmic/endocrine care.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Vision Concern can provide an initial comprehensive eye assessment and referral. Moderate, severe or sight-threatening TED needs specialist ophthalmic/endocrine care.
Vision Concern has no Thamel branch; Lazimpat is a nearby option for initial eye assessment.
Vision Concern has no Thamel branch; Lazimpat is a nearby option for initial eye assessment.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Thyroid eye disease is an autoimmune orbital disease, most often associated with Graves disease, that can cause dryness, swelling, proptosis, pain and double vision.
Yes. Eye symptoms can start before, around the same time as, or after thyroid disease is diagnosed.
No. TED can rarely occur with normal or low thyroid hormone levels.
Rarely, severe corneal exposure or dysthyroid optic neuropathy can cause permanent vision loss.
No. Glasses correct refractive error but do not reverse bulging.
It is usually bilateral but can be markedly asymmetric or appear unilateral.
No. Thyroid control is important, but TED has its own course.
No such on-site service is claimed.
No such on-site surgical service is claimed.
New loss of vision, reduced color vision, missing visual field, severe corneal exposure or rapidly worsening orbital symptoms.
WhatsApp +977 9841466716 with your thyroid diagnosis, recent tests, symptoms, medications and preferred branch.
Vision Concern can provide an initial comprehensive eye examination and recommend ophthalmology or medical referral. Moderate, severe or sight-threatening TED needs specialist care.
Lazimpat: 01-4543117 | Boudha: 01-4562303 | Makalbari: 01-5134042
WhatsApp/Viber: +977 9841466716
Current verified hours: 08:00 AM–08:30 PM daily, including public holidays.
Book Initial Thyroid-Eye AssessmentMedical disclaimer: TED treatment is individualized. Steroids, mycophenolate, biologic infusions, radiotherapy and surgery require specialist care. New vision loss, color desaturation, visual-field loss or severe corneal exposure is urgent.
Vision Concern offers:
Yes.
If your frame is in good condition, we can replace only the prescription lenses with options including:
Many international insurance providers may reimburse eye examinations or prescription eyewear depending on the policy. We recommend checking with your insurer before your visit, and we can provide invoices and supporting documentation when required.